Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia
Anticancer Drug
As directed by a healthcare professional
Decitabine
Injection
Synthetic
Decitabine (Active Pharmaceutical Ingredient)
Store at 2-8C (36-46F). Do not freeze. Keep away from direct sunlight.
Treatment of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Administered intravenously under the supervision of a qualified healthcare professional. Dosage may vary based on patient condition and response.
Decitabine Medicines Trade Information
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
Product Description
We Prissm Pharma are engaged in offering a wide and comprehensive assortment of Decitabine Injections. These decitabine injections offered by us are acknowledged in the market for their usage in treating myelodysplastic syndromes (mds). Along with this, these injections offered by us are nucleoside metabolic inhibitor are termed as hypomethylation agents and are widely known for producing normal blood cells and eliminating abnormal cells in the bone marrow.
Product Details:
Dose/Strength
50 mg
Packaging Type
Glass Bottle
Dosage Form
Vial
Form of Medicine
Injection
Gender
Unisex
Quantity Per Pack
1 vial
Tell us about your requirement
Price:
Quantity
Select Unit
50
100
200
250
500
1000+
Additional detail
Mobile number
Email
Name
Comapny Name
Phone Number
Email Id
City / State
Confirm Your Requirement
Verification Code
Did not receive yet?
Resend OTP
You’re Done!
We have received your requirements and will reply shortly with the best price.